OP-074 A Promising Approach for Septal Ablation in Hypertrophic Obstructive Cardiomyopathy by Ethylene Vinyl Alcohol Copolymer (Onyx)




Objective


Alcohol septal ablation (ASA) has been shown to be an effective treatment in patients with hypertrophic obstructive cardiomyopathy (HOCM) who are refractory to medical treatment. We describe an alternative approach for septal ablation with Onyx. Onyx consists of Ethylene Vinyl Alcohol Copolymer, soluted in Dimethyl-Sulfoxi




Methods


In our method left coronary ostium was cannulated with 6-8F guiding catheter. Septal branch was cannulated with a 4F catheter and a microcatheter. Onyx was instilled through the microcatheter into the septal artery. Immediate polymerization prevents the leak into the left anterior descending coronary artery, and also to the right coronary artery (RCA) via septal collaterals.




Methods


In our method left coronary ostium was cannulated with 6-8F guiding catheter. Septal branch was cannulated with a 4F catheter and a microcatheter. Onyx was instilled through the microcatheter into the septal artery. Immediate polymerization prevents the leak into the left anterior descending coronary artery, and also to the right coronary artery (RCA) via septal collaterals.

Only gold members can continue reading. Log In or Register to continue

Stay updated, free articles. Join our Telegram channel

Nov 27, 2016 | Posted by in CARDIOLOGY | Comments Off on OP-074 A Promising Approach for Septal Ablation in Hypertrophic Obstructive Cardiomyopathy by Ethylene Vinyl Alcohol Copolymer (Onyx)

Full access? Get Clinical Tree

Get Clinical Tree app for offline access